PT766668E - Processos para a preparacao de formas anidras e hidratadas de derivados antihistaminicos da piperidina e de polimorfos e pseudomorfos destes - Google Patents
Processos para a preparacao de formas anidras e hidratadas de derivados antihistaminicos da piperidina e de polimorfos e pseudomorfos destesInfo
- Publication number
- PT766668E PT766668E PT95918278T PT95918278T PT766668E PT 766668 E PT766668 E PT 766668E PT 95918278 T PT95918278 T PT 95918278T PT 95918278 T PT95918278 T PT 95918278T PT 766668 E PT766668 E PT 766668E
- Authority
- PT
- Portugal
- Prior art keywords
- piperidine
- derivatives
- processes
- pseudomorphes
- polymorphes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24573194A | 1994-05-18 | 1994-05-18 | |
US41716195A | 1995-04-11 | 1995-04-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT766668E true PT766668E (pt) | 2002-11-29 |
Family
ID=26937420
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT95918278T PT766668E (pt) | 1994-05-18 | 1995-04-28 | Processos para a preparacao de formas anidras e hidratadas de derivados antihistaminicos da piperidina e de polimorfos e pseudomorfos destes |
Country Status (18)
Country | Link |
---|---|
US (12) | US20010014741A1 (pt) |
EP (3) | EP0766668B1 (pt) |
JP (7) | JPH10500134A (pt) |
CN (3) | CN1148849A (pt) |
AT (1) | ATE220667T1 (pt) |
AU (1) | AU693892B2 (pt) |
CA (3) | CA2585705C (pt) |
DE (1) | DE69527429T2 (pt) |
DK (1) | DK0766668T3 (pt) |
ES (1) | ES2176329T3 (pt) |
FI (1) | FI964565A (pt) |
HK (2) | HK1098467A1 (pt) |
HU (1) | HU227676B1 (pt) |
IL (3) | IL113747A (pt) |
MX (1) | MX9605613A (pt) |
NO (1) | NO315319B1 (pt) |
PT (1) | PT766668E (pt) |
WO (1) | WO1995031437A1 (pt) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9400555D0 (en) * | 1994-01-13 | 1994-03-09 | Short Brothers Plc | Boundery layer control in aerodynamic low drag structures |
DE69527429T2 (de) * | 1994-05-18 | 2003-03-20 | Aventis Pharma Inc | Verfahren zur herstellung von wasserfreien und hydrat-formen von antihistaminischen piperinderivaten, polymerphe und pseudomorphe davon |
AU701042B2 (en) * | 1995-02-28 | 1999-01-21 | Aventisub Llc | Pharmaceutical composition for piperidinoalkanol compounds |
JP4344405B2 (ja) * | 1997-08-26 | 2009-10-14 | アベンティス・ファーマスーティカルズ・インコーポレイテッド | ピペリジノアルカノール−鬱血除去剤の組合せ用医薬組成物 |
IN191492B (pt) * | 1999-05-25 | 2003-12-06 | Ranbaxy Lab Ltd | |
US6613906B1 (en) | 2000-06-06 | 2003-09-02 | Geneva Pharmaceuticals, Inc. | Crystal modification |
CH695216A5 (de) | 2001-02-23 | 2006-01-31 | Cilag Ag | Verfahren zur Herstellung eines nicht hydratisierten Salzes eines Piperidinderivats und eine so erhältliche neue kristalline Form eines solchen Salzes. |
SK13822003A3 (sk) * | 2001-04-09 | 2004-09-08 | Teva Pharmaceutical Industries Ltd. | Polymorfné formy chloridu fexofenadínu |
US20030021849A1 (en) * | 2001-04-09 | 2003-01-30 | Ben-Zion Dolitzky | Polymorphs of fexofenadine hydrochloride |
CZ20033358A3 (en) | 2001-06-18 | 2004-04-14 | Dr. Reddy's Laboratories Ltd. | Novel crystalline forms of 4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl] -1-hydroxybutyl] -a,a-dimethylbenzene acetic acid and its hydrochloride |
US7700779B2 (en) | 2001-06-18 | 2010-04-20 | Dr. Reddy's Laboratories Limited | Crystalline forms of fexofenadine and its hydrochloride |
DE60225694T2 (de) * | 2001-07-31 | 2008-06-26 | Texcontor Etablissement | Neues polymorph von fexo-fenadin |
US20030158227A1 (en) * | 2001-11-08 | 2003-08-21 | Barnaba Krochmal | Polymorphs of fexofenadine base |
US20040044038A1 (en) * | 2002-06-10 | 2004-03-04 | Barnaba Krochmal | Polymorphic form XVI of fexofenadine hydrochloride |
JP3910907B2 (ja) * | 2002-10-29 | 2007-04-25 | 新光電気工業株式会社 | キャパシタ素子及びこの製造方法、半導体装置用基板、並びに半導体装置 |
EP1567533B1 (en) | 2003-07-03 | 2009-03-11 | Teva Pharmaceutical Industries Ltd. | Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation |
GB0319935D0 (en) | 2003-08-26 | 2003-09-24 | Cipla Ltd | Polymorphs |
JP2007532687A (ja) * | 2004-04-26 | 2007-11-15 | テバ ファーマシューティカル インダストリーズ リミティド | フェキソフェナジン塩酸塩の結晶形およびその製造方法 |
ITMI20041143A1 (it) * | 2004-06-08 | 2004-09-08 | Dipharma Spa | Polimorfi di fexofenadina e procedimento per la loro preparazione |
EP1616861A3 (en) * | 2004-06-15 | 2006-02-08 | Dipharma S.p.A. | A process for the preparation of keto compounds |
ITMI20041568A1 (it) * | 2004-07-30 | 2004-10-30 | Dipharma Spa | "polimorfi di fexofenadina base" |
EP1685106A2 (en) * | 2004-09-28 | 2006-08-02 | Teva Pharmaceutical Industries, Inc. | Fexofendadine crystal form and processes for its preparation thereof |
DOP2006000274A (es) * | 2005-12-14 | 2007-10-15 | Sanofi Aventis Us Llc | Formulación de suspensión de fexofenadina |
KR20090037930A (ko) * | 2006-07-11 | 2009-04-16 | 뮤추얼 파마슈티컬 컴퍼니 아이엔씨. | 조절 방출 제형 |
US20090076080A1 (en) * | 2007-09-19 | 2009-03-19 | Protia, Llc | Deuterium-enriched fexofenadine |
EP2105134A1 (en) | 2008-03-24 | 2009-09-30 | Ranbaxy Laboratories Limited | Stable amorphous fexofenadine hydrochloride |
WO2010083360A2 (en) * | 2009-01-16 | 2010-07-22 | Mutual Pharmaceutical Company, Inc. | Controlled-release formulations |
JP2013510113A (ja) | 2009-11-06 | 2013-03-21 | ビーエーエスエフ ソシエタス・ヨーロピア | 4−ヒドロキシ安息香酸及び選択された殺有害生物剤の結晶複合体 |
IT1400965B1 (it) * | 2010-06-15 | 2013-07-05 | Dipharma Francis Srl | Polimorfi di fexofenadina |
ES2403130B1 (es) | 2010-06-15 | 2014-09-29 | Chemelectiva S.R.L. | Forma polimórfica de clorhidrato de fexofenadina, compuestos intermedios y procedimiento para su preparación |
US9420872B2 (en) * | 2010-08-23 | 2016-08-23 | Jason Bird | Apparatus and system for holding game-calling devices |
JP2012087100A (ja) * | 2010-10-21 | 2012-05-10 | Sumitomo Chemical Co Ltd | 形態iのフェキソフェナジン一塩酸塩の製造方法 |
CN104072402B (zh) * | 2014-07-16 | 2016-08-17 | 昆山龙灯瑞迪制药有限公司 | 一种新结晶形式的盐酸非索非那定化合物及其制备方法 |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US631375A (en) * | 1899-04-12 | 1899-08-22 | Ephraim Musselman | Face-protector. |
US3448152A (en) * | 1966-11-03 | 1969-06-03 | Jefferson Chem Co Inc | Amine recovery |
US3878217A (en) * | 1972-01-28 | 1975-04-15 | Richardson Merrell Inc | Alpha-aryl-4-substituted piperidinoalkanol derivatives |
BE794598A (fr) | 1972-01-28 | 1973-05-16 | Richardson Merrell Inc | Nouveaux derives olefiniques de piperidines substituees en 4 et leur procede de preparation |
US3965257A (en) | 1972-01-28 | 1976-06-22 | Richardson-Merrell Inc. | Compositions and methods for the treatment of the symptoms of histamine induced allergic reactions |
US4254130A (en) | 1979-04-10 | 1981-03-03 | Richardson-Merrell Inc. | Piperidine derivatives |
US4285957A (en) * | 1979-04-10 | 1981-08-25 | Richardson-Merrell Inc. | 1-Piperidine-alkanol derivatives, pharmaceutical compositions thereof, and method of use thereof |
US4254129A (en) * | 1979-04-10 | 1981-03-03 | Richardson-Merrell Inc. | Piperidine derivatives |
US4285958A (en) | 1979-04-10 | 1981-08-25 | Richardson-Merrell Inc. | 1-Piperidine-alkylene ketones, pharmaceutical compositions thereof and method of use thereof |
IL63968A (en) | 1980-10-01 | 1985-10-31 | Glaxo Group Ltd | Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it |
US4742175A (en) | 1986-05-07 | 1988-05-03 | Merrell Dow Pharmaceuticals Inc. | Preparation of polymorphically pure terfenadine |
JPH02213431A (ja) * | 1989-02-13 | 1990-08-24 | Kobe Steel Ltd | SiCウィスカ強化Al合金複合材料 |
DE4034218A1 (de) | 1990-10-27 | 1992-04-30 | Merck Patent Gmbh | Verfahren zur herstellung von carebastin |
TW198008B (pt) | 1991-04-08 | 1993-01-11 | Green Cross Corp | |
MX9302076A (es) * | 1992-04-10 | 1994-03-31 | Merrell Dow Pharma | Proceso novedoso para preparar derivados de piperidina. |
US5631375A (en) | 1992-04-10 | 1997-05-20 | Merrell Pharmaceuticals, Inc. | Process for piperidine derivatives |
ATE194913T1 (de) | 1992-05-11 | 2000-08-15 | Merrell Pharma Inc | Verwendung von terfenadin-derivaten als antihistaminika in leberkranken patienten |
EP1214937B1 (en) | 1992-08-03 | 2007-05-30 | Sepracor Inc. | Terfenadine carboxylate and the treatment of dermal irritation |
US5315016A (en) | 1992-10-13 | 1994-05-24 | Nycomed Dak A/S | Process for preparing pure podophyllotoxin |
EP1026147B1 (en) | 1993-06-24 | 2003-11-19 | Albany Molecular Research, Inc. | Compounds useful as intermediates in the production of piperidine derivatives |
CA2181089C (en) | 1993-06-24 | 2000-05-23 | Thomas E. D'ambra | Piperidine derivatives and process for their production |
CN1168717C (zh) | 1993-06-25 | 2004-09-29 | 默里尔药物公司 | 用于制备抗组胺哌啶衍生物的新中间体 |
US6147216A (en) | 1993-06-25 | 2000-11-14 | Merrell Pharmaceuticals Inc. | Intermediates useful for the preparation of antihistaminic piperidine derivatives |
DE69527429T2 (de) * | 1994-05-18 | 2003-03-20 | Aventis Pharma Inc | Verfahren zur herstellung von wasserfreien und hydrat-formen von antihistaminischen piperinderivaten, polymerphe und pseudomorphe davon |
US5576610A (en) | 1994-07-05 | 1996-11-19 | Motorola, Inc. | Method and apparatus for determining battery characteristics |
IL134769A (en) | 1995-02-28 | 2002-02-10 | Aventis Pharma Inc | Pharmaceutical compositions of piperidinoalkanol compounds in solid unit dosage form |
AU701042B2 (en) | 1995-02-28 | 1999-01-21 | Aventisub Llc | Pharmaceutical composition for piperidinoalkanol compounds |
US5574045A (en) * | 1995-06-06 | 1996-11-12 | Hoechst Marion Roussel, Inc. | Oral pharmaceutical composition of piperidinoalkanol compounds in solution form |
JP4344405B2 (ja) * | 1997-08-26 | 2009-10-14 | アベンティス・ファーマスーティカルズ・インコーポレイテッド | ピペリジノアルカノール−鬱血除去剤の組合せ用医薬組成物 |
US6214427B1 (en) * | 1998-08-28 | 2001-04-10 | General Electric Company | Method of making an electronic device having a single crystal substrate formed by solid state crystal conversion |
US6613906B1 (en) | 2000-06-06 | 2003-09-02 | Geneva Pharmaceuticals, Inc. | Crystal modification |
US20020177680A1 (en) * | 2000-08-23 | 2002-11-28 | Hubbell Jeffrey A. | Novel polymer compounds |
US6475942B1 (en) * | 2000-09-05 | 2002-11-05 | General Electric Company | Conversion of polycrystalline alumina to single crystal sapphire using molybdenum doping |
SK13822003A3 (sk) * | 2001-04-09 | 2004-09-08 | Teva Pharmaceutical Industries Ltd. | Polymorfné formy chloridu fexofenadínu |
US7700779B2 (en) * | 2001-06-18 | 2010-04-20 | Dr. Reddy's Laboratories Limited | Crystalline forms of fexofenadine and its hydrochloride |
US20090211514A1 (en) * | 2008-02-26 | 2009-08-27 | Lehigh University | Single crystal conversion process |
-
1995
- 1995-04-28 DE DE69527429T patent/DE69527429T2/de not_active Expired - Lifetime
- 1995-04-28 EP EP95918278A patent/EP0766668B1/en not_active Expired - Lifetime
- 1995-04-28 WO PCT/US1995/004942 patent/WO1995031437A1/en active IP Right Grant
- 1995-04-28 CA CA2585705A patent/CA2585705C/en not_active Expired - Lifetime
- 1995-04-28 DK DK95918278T patent/DK0766668T3/da active
- 1995-04-28 MX MX9605613A patent/MX9605613A/es unknown
- 1995-04-28 AU AU24265/95A patent/AU693892B2/en not_active Expired
- 1995-04-28 CA CA002189007A patent/CA2189007C/en not_active Expired - Lifetime
- 1995-04-28 EP EP10180285A patent/EP2354125A1/en not_active Withdrawn
- 1995-04-28 JP JP7529654A patent/JPH10500134A/ja not_active Withdrawn
- 1995-04-28 ES ES95918278T patent/ES2176329T3/es not_active Expired - Lifetime
- 1995-04-28 AT AT95918278T patent/ATE220667T1/de active
- 1995-04-28 PT PT95918278T patent/PT766668E/pt unknown
- 1995-04-28 HU HU9603167A patent/HU227676B1/hu unknown
- 1995-04-28 CN CN95193122A patent/CN1148849A/zh active Pending
- 1995-04-28 CA CA2449419A patent/CA2449419C/en not_active Expired - Lifetime
- 1995-04-28 CN CNA2003101007654A patent/CN1623985A/zh active Pending
- 1995-04-28 CN CN2006101031426A patent/CN1907967B/zh not_active Expired - Lifetime
- 1995-04-28 EP EP01124314A patent/EP1178041A1/en not_active Withdrawn
- 1995-05-16 IL IL11374795A patent/IL113747A/en not_active IP Right Cessation
- 1995-05-16 IL IL13491795A patent/IL134917A/en not_active IP Right Cessation
-
1996
- 1996-11-14 FI FI964565A patent/FI964565A/fi unknown
- 1996-11-15 NO NO19964859A patent/NO315319B1/no not_active IP Right Cessation
-
2000
- 2000-03-07 IL IL13491700A patent/IL134917A0/xx unknown
-
2001
- 2001-03-09 US US09/803,390 patent/US20010014741A1/en not_active Abandoned
- 2001-03-09 US US09/803,389 patent/US20010012896A1/en not_active Abandoned
- 2001-03-09 US US09/803,476 patent/US20010025106A1/en not_active Abandoned
-
2002
- 2002-03-01 JP JP2002055432A patent/JP4503907B2/ja not_active Expired - Lifetime
- 2002-03-01 JP JP2002055435A patent/JP2002316978A/ja not_active Withdrawn
- 2002-03-01 JP JP2002055431A patent/JP2002308849A/ja active Pending
- 2002-03-01 JP JP2002055433A patent/JP4503908B2/ja not_active Expired - Lifetime
- 2002-03-01 JP JP2002055434A patent/JP4503909B2/ja not_active Expired - Lifetime
- 2002-04-24 US US10/128,926 patent/US20020193600A1/en not_active Abandoned
- 2002-06-03 US US10/162,011 patent/US7138524B2/en not_active Expired - Fee Related
- 2002-06-03 US US10/160,883 patent/US7135571B2/en not_active Expired - Fee Related
- 2002-08-07 US US10/214,262 patent/US20030045721A1/en not_active Abandoned
-
2003
- 2003-03-10 US US10/386,812 patent/US20040014976A1/en not_active Abandoned
-
2006
- 2006-09-25 US US11/534,839 patent/US7662835B2/en not_active Expired - Fee Related
- 2006-09-25 US US11/534,828 patent/US7666881B2/en not_active Expired - Fee Related
-
2007
- 2007-05-04 HK HK07104744.4A patent/HK1098467A1/xx not_active IP Right Cessation
- 2007-10-30 US US11/978,669 patent/US20080167469A1/en not_active Abandoned
- 2007-10-30 US US11/978,670 patent/US20080167471A1/en not_active Abandoned
-
2010
- 2010-02-05 HK HK10101357.3A patent/HK1137742A1/xx not_active IP Right Cessation
- 2010-02-24 JP JP2010038971A patent/JP2010120969A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT766668E (pt) | Processos para a preparacao de formas anidras e hidratadas de derivados antihistaminicos da piperidina e de polimorfos e pseudomorfos destes | |
MX9304649A (es) | Procedimiento para producir 7-(sustituido)-9-[glicilo sustituido]-6-desmetil-6-desoxitetraciclinas. | |
NO304071B1 (no) | Heterocyklisk-cykliske amin-derivater | |
SE9600406D0 (sv) | Novel coompounds | |
DE69401817D1 (de) | Verbesserungen zum herstellen von glasartigem silika | |
HU9301361D0 (en) | Method for producing 4-aryl-piperazines and 4-aryl-piperidines | |
DK55784A (da) | Xylanderivater og fremgangsmaade til fremstilling deraf samt midler indeholdende xylanderivaterne med antithrombose- og hypolipidaemisk virkning | |
FI890245A (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten 1,4-disubstituoitujen piperidinyylijohdannaisten valmistamiseksi | |
PT956286E (pt) | Sintese de terfenadina e derivados | |
TW362096B (en) | Novel piperidine derivatives and the process for preparing the same | |
PT97796A (pt) | Processo para a preparacao de piperidinas substituidas | |
AR004279A1 (es) | Procedimientos para preparar 3-(1-piperazinil)-1,2-benzoisotiazol | |
ATE258926T1 (de) | Verfahren zur herstellung von ranitidin | |
DK0381114T3 (da) | Exo-3,4-O-benzyliden-3"-demethylchartreusin og salte deraf | |
ES1012448Y (es) | Maquina para la fabricacion de ladrillos de aspecto artesanal o mudejar. | |
BR9610392A (pt) | Processo para a preparação de derivados de rodanina substituídos com benzila | |
SE9503757D0 (sv) | Process for the production of ranitidine |